Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CL.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BR.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
XBB.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.256ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.248ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.559ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.406ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ER.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.640ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.6 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.9 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XUENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.3 (Omicron)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.372ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.425ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used